Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| American Well CorpAMWL · Entity 2112 | Chief Financial Officer | October 01, 2026 | October 05, 2026 |
| Talkspace, Inc.TALK · Entity 22747 | President and COO | July 15, 2021 | October 20, 2021 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Executive VP, COO and CFO | December 13, 2018 | December 17, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
American Well Corp
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 223,906 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Sale · Disposed 4,282 · Balance 223,906 F1: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on October 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on October 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.
Talkspace, Inc.
Report date July 15, 2021 · Filed October 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 788,967 |
Reported balance
After 2021-10-18 transaction · row 1
1 source rowRow 1 · 2021-10-18 · Grant · Acquired 247,500 · Balance 788,967 F1: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in 16 substantially equally installments on a quarterly basis, subject to the Reporting Person's continued service with the Company through each vesting date. |
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $5.81 · Expires 2031-07-14 | Direct | 990,000 |
Reported balance
After 2021-07-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-07-15 · Grant · Acquired 990,000 · Balance 990,000 F2: The stock option vests in 16 substantially equally installments on a quarterly basis, subject to the Reporting Person's continued service with the Company through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Talkspace, Inc. common stock. The RSUs vest in 16 substantially equally installments on a quarterly basis, subject to the Reporting Person's continued service with the Company through each vesting date.
F2: The stock option vests in 16 substantially equally installments on a quarterly basis, subject to the Reporting Person's continued service with the Company through each vesting date.
Teladoc Health, Inc.
Report date December 13, 2018 · Filed December 17, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,000 |
Ending reported balance
After 2018-12-13 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2018-12-13 · Exercise / conversion · Acquired 1,001 · Balance 3,658 Row 2 · 2018-12-13 · Exercise / conversion · Acquired 684 · Balance 4,342 Row 3 · 2018-12-13 · Exercise / conversion · Acquired 2,284 · Balance 6,626 Row 4 · 2018-12-13 · Exercise / conversion · Acquired 3,081 · Balance 9,707 Row 5 · 2018-12-13 · Exercise / conversion · Acquired 293 · Balance 10,000 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.67 · Expires 2023-12-11 | Direct | 7,008 |
Reported balance
After 2018-12-13 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-12-13 · Exercise / conversion · Disposed 1,001 · Balance 7,008 F1: The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.01 · Expires 2024-09-10 | Direct | 6,151 |
Reported balance
After 2018-12-13 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-12-13 · Exercise / conversion · Disposed 684 · Balance 6,151 F2: The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.01 · Expires 2024-12-22 | Direct | 29,692 |
Reported balance
After 2018-12-13 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-12-13 · Exercise / conversion · Disposed 2,284 · Balance 29,692 F3: The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.21 · Expires 2026-03-07 | Direct | 83,194 |
Reported balance
After 2018-12-13 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-12-13 · Exercise / conversion · Disposed 3,081 · Balance 83,194 F4: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.30 · Expires 2027-03-03 | Direct | 102,352 |
Reported balance
After 2018-12-13 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-12-13 · Exercise / conversion · Disposed 293 · Balance 102,352 F5: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter.
F2: The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
F3: The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
F4: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
F5: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2018 Filed Apr 6, 2018 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,002 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-005480 · edgar.xml · derivative · entry 8 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,020 Underlying: Common Stock · 1,002 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| April 06, 2018 Filed Apr 6, 2018 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 683 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-005480 · edgar.xml · derivative · entry 7 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,303 Underlying: Common Stock · 683 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| April 06, 2018 Filed Apr 6, 2018 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,285 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-005480 · edgar.xml · derivative · entry 6 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,964 Underlying: Common Stock · 2,285 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| April 06, 2018 Filed Apr 6, 2018 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-18-005480 · edgar.xml · derivative · entry 5 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,900 Underlying: Common Stock · 10,000 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| April 06, 2018 Filed Apr 6, 2018 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,002 | $1.67 | $1,673.34 |
DisclosureSEC source: 0001179110-18-005480 · edgar.xml · nonDerivative · entry 4 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2018 Filed Apr 6, 2018 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,285 | $6.01 | $13,732.85 |
DisclosureSEC source: 0001179110-18-005480 · edgar.xml · nonDerivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2018 Filed Apr 6, 2018 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 683 | $6.01 | $4,104.83 |
DisclosureSEC source: 0001179110-18-005480 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2018 Filed Apr 6, 2018 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 10,000 | $12.21 | $122,100.00 |
DisclosureSEC source: 0001179110-18-005480 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:24 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Unit · Derivative | 24,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003540 · edgar.xml · derivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,849 Underlying: Common Stock · 24,849 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 1, 2019. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 1, 2019. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:24 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 105,965 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-18-003540 · edgar.xml · derivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,965 Underlying: Common Stock · 105,965 shares Expires 2028-03-01 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on March 1, 2019. The remainder of the shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003294 · edgar.xml · derivative · entry 5 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,377 Underlying: Common Stock · 4,793 shares Expires 2027-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 19,170 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,002 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-003294 · edgar.xml · derivative · entry 4 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,022 Underlying: Common Stock · 1,002 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 100,000 | $39.60 | $3,960,000.00 |
DisclosureSEC source: 0001179110-18-003294 · edgar.xml · nonDerivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,753 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 14, 2017. F3 · price: Represents the weighted average price of transactions ranging from $37.05 to $40.95. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares [purchased/ sold] at each separate price. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,793 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-003294 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,002 | $1.67 | $1,673.34 |
DisclosureSEC source: 0001179110-18-003294 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2018 Filed Feb 22, 2018 23:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 31,285 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-002637 · edgar.xml · derivative · entry 6 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,249 Underlying: Common Stock · 31,285 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2018 Filed Feb 22, 2018 23:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 684 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-002637 · edgar.xml · derivative · entry 5 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,986 Underlying: Common Stock · 684 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2018 Filed Feb 22, 2018 23:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,002 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-002637 · edgar.xml · derivative · entry 4 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,024 Underlying: Common Stock · 1,002 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2018 Filed Feb 22, 2018 23:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 31,285 | $6.01 | $188,022.85 |
DisclosureSEC source: 0001179110-18-002637 · edgar.xml · nonDerivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2018 Filed Feb 22, 2018 23:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 684 | $6.01 | $4,110.84 |
DisclosureSEC source: 0001179110-18-002637 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2018 Filed Feb 22, 2018 23:39 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,002 | $1.67 | $1,673.34 |
DisclosureSEC source: 0001179110-18-002637 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 25,834 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-002032 · edgar.xml · derivative · entry 6 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,534 Underlying: Common Stock · 25,834 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 25,834 | $6.01 | $155,262.34 |
DisclosureSEC source: 0001179110-18-002032 · edgar.xml · nonDerivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2018 Filed Feb 13, 2018 23:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option · Derivative | 2,286 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-002032 · edgar.xml · derivative · entry 5 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,368 Underlying: Common Stock · 2,286 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 22, 2018 Filed Feb 13, 2018 23:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 18,460 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-002032 · edgar.xml · derivative · entry 4 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,670 Underlying: Common Stock · 18,460 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 22, 2018 Filed Feb 13, 2018 23:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,286 | $6.01 | $13,738.86 |
DisclosureSEC source: 0001179110-18-002032 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2018 Filed Feb 13, 2018 23:33 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 18,460 | $6.01 | $110,944.60 |
DisclosureSEC source: 0001179110-18-002032 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 23:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 680 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-000891 · edgar.xml · derivative · entry 6 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,130 Underlying: Common Stock · 680 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 23:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,023 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-000891 · edgar.xml · derivative · entry 5 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,019 Underlying: Common Stock · 12,023 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the shares on December 12, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 23:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 501 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-000891 · edgar.xml · derivative · entry 4 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,007 Underlying: Common Stock · 501 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the shares on December 12, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 23:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 680 | $6.01 | $4,086.80 |
DisclosureSEC source: 0001179110-18-000891 · edgar.xml · nonDerivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 23:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 12,023 | $1.67 | $20,078.41 |
DisclosureSEC source: 0001179110-18-000891 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 23:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 501 | $1.67 | $836.67 |
DisclosureSEC source: 0001179110-18-000891 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2017 Filed Dec 4, 2017 22:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $32.99 | $989,700.00 |
DisclosureSEC source: 0001104659-17-071716 · a4.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,203 Read SEC document |
| November 27, 2017 Filed Nov 28, 2017 22:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,019 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-17-014670 · edgar.xml · derivative · entry 4 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,508 Underlying: Common Stock · 9,019 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on December 12, 2014. The remainder of the shares vest in 36 equal monthly installments. Read SEC document |
| November 27, 2017 Filed Nov 28, 2017 22:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 25,297 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-17-014670 · edgar.xml · derivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,297 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the shares on December 31, 2013. The remainder of the shares vested in 36 equal monthly installments. Read SEC document |
| November 27, 2017 Filed Nov 28, 2017 22:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,019 | $1.67 | $15,061.73 |
DisclosureSEC source: 0001179110-17-014670 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2017 Filed Nov 28, 2017 22:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 25,297 | $1.07 | $27,067.79 |
DisclosureSEC source: 0001179110-17-014670 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,000 | $27.96 | $279,600.00 |
DisclosureSEC source: 0001179110-17-014303 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 887 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 15, 2017. F2 · price: Represents the weighted average price of transactions ranging from $27.45 to $28.35. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 17, 2017 Filed Oct 18, 2017 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,000 | $34.03 | $340,300.00 |
DisclosureSEC source: 0001179110-17-013345 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,887 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 15, 2017. F3 · price: Represents the weighted average price of transactions ranging from $34.00 to $34.15. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 16, 2017 Filed Oct 18, 2017 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $32.37 | $809,250.00 |
DisclosureSEC source: 0001179110-17-013345 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,887 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 15, 2017. F2 · price: Represents the weighted average price of transactions ranging from $31.45 to $32.78. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,000 | $34.04 | $340,400.00 |
DisclosureSEC source: 0001179110-17-013082 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,887 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 15, 2017. F2 · price: Represents the weighted average price of transactions ranging from $34.00 to $34.20. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 22, 2017 Filed Sep 25, 2017 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 9,100 | $32.74 | $297,934.00 |
DisclosureSEC source: 0001179110-17-012649 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,887 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 15, 2017. F3 · price: Represents the weighted average price of transactions ranging from $32.00 to $33.00. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2017 Filed Sep 25, 2017 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 15,900 | $31.46 | $500,214.00 |
DisclosureSEC source: 0001179110-17-012649 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,987 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on August 15, 2017. F2 · price: Represents the weighted average price of transactions ranging from $30.45 to $32.10. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 25, 2017 Filed May 30, 2017 21:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 19,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008196 · edgar.xml · derivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,170 Underlying: Common Stock · 19,170 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning March 3, 2018. F2 · derivative.expiration_date: The restricted stock unit vests in four equal annual installments beginning March 3, 2018. Read SEC document |
| May 17, 2017 Filed May 19, 2017 20:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 100,000 | $27.70 | $2,770,000.00 |
DisclosureSEC source: 0001179110-17-007613 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,887 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 17, 2017. F2 · price: Represents the weighted average price of transactions ranging from $27.58 to $28.15. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 23:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 59,100 | $25.46 | $1,504,686.00 |
DisclosureSEC source: 0001179110-17-006157 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,887 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 16, 2016. F2 · price: Represents the weighted average price of transactions ranging from $25.05 to $25.75. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 23:44 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 170,820 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-17-004167 · edgar.xml · derivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,820 Underlying: Common Stock · 170,820 shares Expires 2027-03-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on March 3, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| January 26, 2017 Filed Jan 30, 2017 23:45 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 900 | $20.00 | $18,000.00 |
DisclosureSEC source: 0001179110-17-001350 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,987 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 16, 2016. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 23:59 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,000 | $17.84 | $178,400.00 |
DisclosureSEC source: 0001179110-17-001077 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,887 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 16, 2016. F1 · price: Represents the weighted average price of transactions ranging from $17.20 to $18.30. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.